# RIS Country Representatives

**Funder:** EIT Health
**Duration:** 2027–2028
**Consortium:** Optional — single organisation or national consortium representing at least two sides of the Knowledge Triangle (education, research, industry), all partners in the same eligible country
**Eligible countries:** HR, CZ, EE, GR, HU, LV, MT, RO, RS, SI, TR
**Official call:** https://eithealth.eu/opportunity/eit-health-country-representatives/
**Last updated:** 13 Sept 2026

## Eligibility & scope

Seeks organisations to act as national representatives for 2027–2028 in selected EIT Regional Innovation Scheme (RIS) countries, strengthening healthcare innovation ecosystems, supporting innovators/start-ups and promoting EIT Health programmes. Applicants must be registered legal entities established in one of the eligible countries.

## Summary

EIT Health funds organisations to act as national representatives for its Regional Innovation Scheme (RIS) in eleven eligible countries across Central, Eastern and Southern Europe, for the 2027-2028 period. Applicants can be a single legal entity or a national consortium spanning at least two sides of the Knowledge Triangle, education, research or industry, and the role involves strengthening the local healthcare innovation ecosystem, supporting innovators and start-ups, and promoting EIT Health programmes in-country.

## Who should apply

- Legal entities registered in one of the eligible RIS countries (HR, CZ, EE, GR, HU, LV, MT, RO, RS, SI, TR)
- Organisations with an established role in healthcare innovation, start-up support, or research-industry engagement
- Single applicants or national consortia covering at least two sides of the Knowledge Triangle (education, research, industry)
- All consortium partners based in the same eligible country

## Key dates

- Representative role covers the 2027-2028 period

## Tips for applicants

- Clearly map which two (or more) Knowledge Triangle sides your organisation or consortium covers, this is a stated eligibility requirement, not just a preference.
- Since all partners must be based in the same eligible country, cross-border consortia will not qualify, keep partnerships domestic.
- Emphasise existing ties to local start-ups and innovators, since ecosystem support and start-up engagement are named parts of the role.

## Frequently asked questions

### Which countries are eligible for the EIT Health RIS Country Representatives call?

Croatia, Czechia, Estonia, Greece, Hungary, Latvia, Malta, Romania, Serbia, Slovenia and Turkey.

### Can a single organisation apply, or is a consortium required?

A consortium is optional, a single organisation or a national consortium can apply, as long as at least two sides of the Knowledge Triangle (education, research, industry) are represented.

### What does the RIS Country Representative role involve?

It involves strengthening the national healthcare innovation ecosystem, supporting innovators and start-ups, and promoting EIT Health programmes in the country.

### How long does the RIS Country Representative role last?

The role covers the 2027-2028 period.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/eit-health-ris-country-representatives-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).